T

    Thermo Fisher Scientific Inc (TMO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $617.60
    -4.58 (-0.74%)

    Market Cap: $230.05B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    98%(39/40)
    Avg Surprise
    +5.98%
    Streak
    12 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$6.40
    Range$6.33 - $6.56
    22 analysts
    EPS Revisions
    11
    0
    7d
    11
    6
    30d
    EPS Estimate Drift
    90d ago$6.35-0.8%
    60d ago$6.37-0.6%
    30d ago$6.37-0.6%
    7d ago$6.41+0.0%
    Current$6.40
    Revenue Consensus
    $12.0B
    Range$11.8B - $12.1B
    20 analysts
    Dec 31, 2026
    EPS Consensus$7.76
    Range$7.60 - $7.90
    26 analysts
    Revenue Consensus
    $13.3B
    Range$13.2B - $13.6B
    25 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    -$7.76---
    Sep 26EST
    -$6.40---
    Jun 26
    $6.03$5.71+5.60%Beat+12.5%
    Mar 26
    $5.44$5.24+3.82%Beat+5.6%
    Dec 25
    $6.57$6.45+1.86%Beat+7.7%
    Sep 25
    $5.79$5.50+5.27%Beat+9.7%
    Jun 25
    $5.36$5.23+2.49%Beat-0.2%
    Mar 25
    $5.15$5.10+0.98%Beat+0.8%
    Dec 24
    $6.10$5.94+2.69%Beat+7.6%
    Sep 24
    $5.28$5.25+0.57%Beat-7.2%
    Jun 24
    $5.37$5.12+4.88%Beat+4.3%
    Mar 24
    $5.11$4.71+8.49%Beat+1.6%
    Dec 23
    $5.67$5.64+0.53%Beat+5.0%
    Sep 23
    $5.69$5.61+1.43%Beat+12.0%
    Jun 23
    $5.15$5.43-5.16%Miss-6.5%
    Mar 23
    $5.03$5.03+0.00%Beat-30.6%
    Dec 22
    $5.40$5.20+3.85%Beat-17.4%
    Sep 22
    $5.08$4.82+5.39%Beat-11.8%
    Jun 22
    $5.51$4.98+10.64%Beat-1.6%
    Mar 22
    $7.25$6.21+16.75%Beat+0.6%
    Dec 21
    $6.54$5.27+24.10%Beat-7.8%
    Sep 21
    $5.76$4.70+22.55%Beat+2.3%
    Jun 21
    $5.60$5.47+2.38%Beat+44.0%
    Mar 21
    $7.21$6.68+7.93%Beat+145.2%
    Dec 20
    $7.09$6.57+7.91%Beat+99.7%
    Sep 20
    $5.63$4.30+30.93%Beat+91.5%
    Jun 20
    $3.89$2.89+34.60%Beat+28.0%
    Mar 20
    $2.94$2.82+4.26%Beat+4.6%
    Dec 19
    $3.55$3.54+0.28%Beat+9.2%
    Sep 19
    $2.94$2.89+1.73%Beat+12.2%
    Jun 19
    $3.04$3.00+1.33%Beat+10.5%
    Mar 19
    $2.81$2.74+2.55%Beat+12.4%
    Dec 18
    $3.25$3.18+2.20%Beat+16.5%
    Sep 18
    $2.62$2.56+2.34%Beat+13.4%
    Jun 18
    $2.75$2.63+4.56%Beat+19.6%
    Mar 18
    $2.50$2.41+3.73%Beat+20.2%
    Dec 17
    $2.79$2.67+4.49%Beat+15.8%
    Sep 17
    $2.31$2.25+2.67%Beat+13.8%
    Jun 17
    $2.30$2.27+1.32%Beat-
    Mar 17
    $2.08$2.02+2.97%Beat-
    Dec 16
    $2.41$2.38+1.26%Beat-
    Sep 16
    $2.03$1.97+3.05%Beat-

    Dividends

    Dividend Metrics

    Yield0.29%
    Annual/Share$1.80
    Payout Ratio7.41%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+12.75%
    5Y CAGR+14.34%
    View TMO's full dividend history

    Key Metrics

    Valuation
    P/E Ratio25.92EV/EBITDA22.55x
    Price/FCF31.31xFCF Yield3.19%
    Profitability
    Profit Margin15.00%Operating Margin18.80%
    ROE13.50%ROIC7.88%
    Financial Health
    Debt/Equity0.81xInterest Coverage5.45x
    Current Ratio1.55xQuick Ratio1.18x
    Trading Statistics
    Beta0.85Avg Volume1.67M
    52-Week High$647.0052-Week Low$434.83

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$622.05
    SMA 20$605.72
    SMA 50$560.54
    SMA 200$534.91
    EMA 10$619.17
    EMA 20$605.66
    EMA 50$569.83
    EMA 200$528.45

    MACD

    Line: 19.42Signal: 20.64Hist: -1.22

    ADX

    ADX: 38.3+DI: 30.6-DI: 15.6

    Aroon & PSAR

    Aroon Up84.0
    Aroon DownN/A
    PSAR$646.41

    Bollinger Bands

    Upper Band$647.60
    Lower Band$563.85
    %B Position1383%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    62.8

    Momentum Oscillators

    Stoch %K64.9
    Stoch %D72.0
    Williams %R-43.9
    ROC (10d)5.5%
    Momentum32.09
    CCI (20d)45.1
    MFI (14d)51.6

    Volatility Measures

    ATR (14d)$15.71(2.5%)
    StdDev (20d)20.94
    Hist Vol23.7%(Moderate)

    Volume Flow

    VWAP$616.22
    OBV5.1M
    AD Line-77.6M
    CMF (20d)0.379

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.8x
    VWMA (20d)$606.42

    Pivot Points

    R3$641.52
    R2$635.76
    R1$628.97
    Pivot Point$623.21
    S1$616.42
    S2$610.66
    S3$603.87

    Advanced Oscillators

    TSI39.74
    Ultimate Osc60.7
    KST121.44

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$11.99B$11.01B$12.21B$11.12B$10.86B$10.36B$11.39B$10.60B$10.54B$10.35B$10.89B$10.57B
    Cost of Revenue$7.11B$6.58B$7.20B$6.54B$6.45B$6.13B$6.57B$6.27B$6.19B$6.14B$6.49B$6.26B
    Gross Profit$4.88B$4.43B$5.01B$4.58B$4.41B$4.24B$4.82B$4.33B$4.35B$4.21B$4.39B$4.32B
    Operating Expenses$2.79B$2.57B$2.76B$2.64B$2.57B$2.52B$2.81B$2.49B$2.53B$2.54B$2.54B$2.45B
    R&D$364.00M$336.00M$357.00M$346.00M$352.00M$342.00M$374.00M$346.00M$339.00M$331.00M$327.00M$319.00M
    SG&A$2.33B$2.18B$2.35B$2.16B$2.14B$2.08B$2.20B$2.10B$2.11B$2.18B$2.13B$2.05B
    Operating Income$2.09B$1.86B$2.25B$1.94B$1.83B$1.72B$2.02B$1.84B$1.82B$1.66B$1.85B$1.86B
    Interest Income$0$233.00M$259.00M$234.00M$0$203.00M$227.00M$277.00M$295.00M$279.00M$309.00M$246.00M
    Interest Expense$0$354.00M$365.00M$347.00M$0$303.00M$317.00M$356.00M$354.00M$363.00M$390.00M$359.00M
    Income Before Tax$1.92B$1.73B$2.15B$1.83B$1.71B$1.62B$1.94B$1.74B$1.76B$1.59B$1.74B$1.76B
    Income Tax Expense$167.00M$70.00M$153.00M$207.00M$92.00M$95.00M$149.00M$99.00M$128.00M$281.00M$133.00M$53.00M
    Net Income$1.74B$1.66B$1.97B$1.62B$1.62B$1.51B$1.82B$1.63B$1.55B$1.33B$1.61B$1.70B
    EBITDA$2.90B$2.59B$2.99B$2.60B$2.52B$2.42B$2.77B$2.56B$2.62B$2.51B$2.66B$2.73B
    EBIT$2.09B$1.85B$2.26B$1.94B$1.83B$1.72B$2.03B$1.82B$1.82B$1.67B$1.82B$1.88B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    The Diversification Test Every Investor Should Run (Built Into GNG)

    Counting holdings is misleading - a 12-stock, 10-industry model that appeared diversified lost most diversification once positions were grouped by underlying return drivers Academic rules conflict on count - Evans & Archer (1968) says 10-15 stocks, Statman (1987) 30-40, Statman (2004) >300, all assume near-zero pairwise correlation (~0.08) Portfolio risk decomposes into idiosyncratic risk/N plus average covariance - the covariance is the non-diversifiable floor that additional names cannot breach Run the 20-minute test - build a pairwise correlation matrix or regress returns by economic drivers, compute average covariance and effective number of independent bets GNG embeds this test - prioritize holdings with distinct economic engines, size concentration to your demonstrated edge, and use ETF sleeves if you lack research bandwidth (peer uses 50% ETF)

    Unknown Author
    6/29/26
    350
    Portfolio Construction
    Also mentions:
    DHR
    TMO
    ODFL
    INTU
    UNP

    The Biggest Healthcare Disconnect In Decades - And The Stocks I’m Watching

    Healthcare has hit a 26-year relative low, but weakness alone does not make the sector a buy. AI-led capital flows, patent cliffs, IRA pricing pressure, and GLP-1 disruption explain much of the selloff. I prefer selective exposure: picks-and-shovels, AI-driven platforms, and discounted turnarounds over broad healthcare ETFs. TMO, WST, LLY, ISRG, and PFE stand out as stocks to watch, each with different risk/reward profiles.

    Unknown Author
    5/25/26
    435
    Healthcare Stocks
    Dividend Investing
    value investing
    Also mentions:
    TMO
    WST
    LLY
    ISRG
    PFE

    Government Contracts

    Gov Obligations (TTM)
    $83.26M
    Gov Obligations / Revenue
    0.2%
    Obligations YoY
    -24.8%
    Active Awards
    915
    New Awards (TTM)
    494
    Avg Remaining Term
    5.8 mo

    Top agency: Department of Justice at 26.6% of trailing twelve month obligations across 16 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    15F06726F0000364Department of JusticeFederal Bureau of Investigation$9.80MMar 13, 2026
    1333ND26PNB030039Department of CommerceNational Institute of Standards and Technology$4.49MMar 27, 2026
    75N92025P00391Department of Health and Human ServicesNational Institutes of Health$1.94MSep 22, 2025
    12639526F0606Department of AgricultureAnimal and Plant Health Inspection Service$1.50MJun 5, 2026
    36C26326N0198Department of Veterans AffairsDepartment of Veterans Affairs$1.26MOct 1, 2025
    75N98026F00135Department of Health and Human ServicesNational Institutes of Health$1.23MMay 11, 2026
    70B04C26P00000067Department of Homeland SecurityU.S. Customs and Border Protection$1.22MApr 1, 2026
    36C26226P0487Department of Veterans AffairsDepartment of Veterans Affairs$1.08MFeb 10, 2026
    75N98026F00203Department of Health and Human ServicesNational Institutes of Health$999832Jun 25, 2026
    N0010426PBJ98Department of DefenseDepartment of the Navy$899640Feb 11, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Frequently Asked Questions About TMO

    What is TMO's current dividend yield?
    Thermo Fisher Scientific Inc (TMO) has a current dividend yield of 0.29%.
    Does TMO pay dividends?
    Yes, Thermo Fisher Scientific Inc pays dividends with a current yield of 0.29%.
    What is TMO's P/E ratio?
    Thermo Fisher Scientific Inc has a price-to-earnings (P/E) ratio of 25.92.
    What is TMO's market cap?
    Thermo Fisher Scientific Inc (TMO) has a market capitalization of $230.05B with a current stock price of $617.60.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.